Effectiveness of treatment regimens for Typhoid fever in the nalidixic acid-resistant S. typhi (NARST) era in South India

Abstract

The epidemiology of typhoid fever in South Asia has changed. Multi-drug resistant (MDR) Salmonella typhi (S. typhi) is now frequently resistant to nalidixic acid and thus labelled NARST. Treatment failure with the use of fluoroquinolones has been widely noted, forcing clinicians to adopt alternative treatment strategies. In this observational study, we looked at various treatment regimens and correlated clinical and microbiological outcomes. In 146 hospitalised adults, the median minimum inhibitory concentration (MIC) for ciprofloxacin was 0.38 µg/mL with a median fever clearance time (FCT) of eight days (range = 2–35 days). Of the regimens used, gatifloxacin and azithromycin had a shorter FCT of six days compared to ceftriaxone (ten days; P < 0.001). Though mortality and relapse in our cohort was low, NARST seemed to correlate with mortality (P = 0.006). Gatifloxacin or azithromycin clearly emerge as the drugs of choice for treatment of typhoid in South India.

Keywords

Typhoid fever treatment failure gatifloxacin azithromycin India

Get full access to this article

View all access options for this article.

References

Rupali

Abraham

Jesudason

et al.

Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis 2004; 49: 1–3.

Dolecek

Tran

Nguyen

et al.

A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. PLoS One 2008; 3: e2188–e2188.

Park-Wyllie

Juurlink

Kopp

et al.

Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354: 1352–1361.

Capoor

Rawat

Nair

et al.

In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever. J Med Microbiol 2007; 56: 1490–1494.

Basnyat

Maskey

Zimmerman

et al.

Enteric (typhoid) fever in travelers. Clin Infect Dis 2005; 41: 1467–1472.

Thaver

Zaidi

Critchley

et al.

A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. BMJ 2009; 338: b1865–b1865.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Ninth Edition, Wayne, PA: CLSI, 2006.

European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 2.0, Basel: EUCAST, 2012.

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. M100-S23, Wayne, PA: CLSI, 2013.

10.

Kadhiravan

Wig

Kapil

et al.

Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 2005; 5: 37–37.

11.

Sinha

Sazawal

Kumar

et al.

Typhoid fever in children aged less than 5 years. Lancet 1999; 354: 734–737.

12.

Jesudason

Malathy

John

. Trend of increasing levels of minimum inhibitory concentration of ciprofloxacin to Salmonella typhi. Indian J Med Res 1996; 103: 247–249.

13.

Kabra

Madhulika Talati

et al.

Multidrug-resistant typhoid fever. Trop Doct 2000; 30: 195–197.

14.

Parry

Thompson

Vinh

et al.

Risk factors for the development of severe typhoid fever in Vietnam. BMC Infect Dis 2014; 14: 73–73.

15.

Bhutta

Naqvi

Razzaq

et al.

Multidrug-resistant typhoid in children: presentation and clinical features. Rev Infect Dis 1991; 13: 832–836.

16.

Singhal

Gupta

Kale

et al.

Trends in antimicrobial susceptibility of Salmonella Typhi from North India (2001-2012). Indian J Med Microbiol 2014; 32: 149–152.

17.

Shanahan

Jesudason

Thomson

et al.

Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India. J Clin Microbiol 1998; 36: 1595–1600.

18.

Dutta

Sur

Manna

et al.

Rollback of Salmonella enterica serotype Typhi resistance to chloramphenicol and other antimicrobials in Kolkata, India. Antimicrob Agents Chemother 2005; 49: 1662–1663.

19.

Thong

Bhutta

Pang

. Multidrug-resistant strains of Salmonella enterica serotype typhi are genetically homogenous and coexist with antibiotic-sensitive strains as distinct, independent clones. Int J Infect Dis 2000; 4: 194–197.

20.

World Health Organization. Background document: the diagnosis, treatment and prevention of typhoid fever, Geneva: World Health Organization, 2003.